All reviews

Pyroptosis · Antibody review

Caspase-1

Proteintech · 22915-1-AP

The early blots were clear. This time, p10 appears with a longer exposure, while other cleavage bands show little difference.

Join the discussion

01Experimental images

02Observations

After about three years

I bought this antibody about three years ago. It worked very well at first, with clear pro-caspase-1 and several cleavage bands. The pattern in this experiment differs from those early results.

Short exposure: less precursor and a possible p43 band

At the shorter exposure, the pro-caspase-1 band is weaker, while lanes 7 and 10 show a prominent band between 40 and 55 kDa, possibly p43. Changes in this region are easier to see than the lower-molecular-weight bands.

Longer exposure: p10 becomes visible

With a longer exposure, p10 is visible in lanes 3–6. The other cleavage bands show little difference between groups and are less distinct than in my early experiments.

03Protein background

Caspase-1 is usually present as the approximately 45–46 kDa precursor pro-caspase-1. After inflammasome assembly, the precursor is recruited, dimerizes and undergoes self-cleavage to form active p33/p10. Further cleavage removes the CARD domain and releases p20/p10 from the inflammasome; in cells, this release can reduce its activity. Caspase-1 also processes IL-1β, IL-18 and GSDMD. Western blots may therefore show full-length p45/46 together with fragments such as p33, p20 and p10, depending on the antibody epitope, cell type and sampling time.

04Experimental conditions

Sample
Human THP-1 monocytes
Application
Western blot (WB)
Primary antibody dilution
1:3000
Gel
4–20% gradient gel
Electrophoresis
200 V, 45 min
Transfer
320 mA, 30 min
Membrane
0.2 μm nitrocellulose
Blocking
No blocking
Secondary antibody
1:5000, 1 h
Protein loading
Not recorded

Comments & discussion

No sign-up. Nickname optional.
Your experience is worth sharing.

Ask specific questions and respect different experimental results.

0 / 2000 · Comments appear after review

Loading comments…